JAMA Otolaryngology–Head & Neck Surgery : Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab
- Author
- American Medical Association, 2017
- Published
- Thu 31 Jul 2025
- Episode Link
- https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jamaoto.2025.2571
Interview with Jennifer M. Johnson, MD, PhD and Adam J. Luginbuhl, MD authors of A Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab. Hosted by Paul C. Bryson, MD MBA.
Related Content:
